Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurel Perren

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potentialMartin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2013
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic originAbbas Agaimy, Katharina Erlenbach-Wünsch, Björn Konukiewitz, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomasMargarete Maier-Woelfle, Michael Brändle, Paul Komminoth, et al.
Journal of Pathology Informatics|March 1, 2024
External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter studySebastian Stenman, Sylvain Bétrisey, Paula Vainio, et al.
IEEE Transactions on Bio-Medical Engineering|February 4, 2026
Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetryPaulo Sampaio, Davide Scandella, C H Lucas Patty, et al.
Endocrine Pathology|December 23, 2022
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine TumorsMarco Schiavo Lena, Stefano Partelli, Valentina Andreasi, et al.
Neuroendocrinology|December 9, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratificationGünter Klöppel, Anne Couvelard, Aurel Perren, et al.
Endocrine-Related Cancer|October 5, 2016
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumorsSimona Falletta, Stefano Partelli, Corrado Rubini, et al.
International Journal of Cancer|April 27, 2018
Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumorsSebastian Krug, Rami Abbassi, Heidi Griesmann, et al.
The American Journal of Surgical Pathology|March 16, 2005
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changesMartin Anlauf, Daniel Wieben, Aurel Perren, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potentialMartin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2013
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic originAbbas Agaimy, Katharina Erlenbach-Wünsch, Björn Konukiewitz, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomasMargarete Maier-Woelfle, Michael Brändle, Paul Komminoth, et al.
Journal of Pathology Informatics|March 1, 2024
External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter studySebastian Stenman, Sylvain Bétrisey, Paula Vainio, et al.
IEEE Transactions on Bio-Medical Engineering|February 4, 2026
Rapid, label-free cancer detection in fresh pancreatic tissue using deep learning and multispectral Mueller matrix polarimetryPaulo Sampaio, Davide Scandella, C H Lucas Patty, et al.
Endocrine Pathology|December 23, 2022
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine TumorsMarco Schiavo Lena, Stefano Partelli, Valentina Andreasi, et al.
Neuroendocrinology|December 9, 2008
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratificationGünter Klöppel, Anne Couvelard, Aurel Perren, et al.
Endocrine-Related Cancer|October 5, 2016
mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumorsSimona Falletta, Stefano Partelli, Corrado Rubini, et al.
International Journal of Cancer|April 27, 2018
Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumorsSebastian Krug, Rami Abbassi, Heidi Griesmann, et al.
The American Journal of Surgical Pathology|March 16, 2005
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changesMartin Anlauf, Daniel Wieben, Aurel Perren, et al.
Pageof 24